Antares Pharma, Inc. (ATRS)

Deferred Revenue

$3.10M

Quarterly · Period ending: · USD

ATRS logo

ATRS Deferred Revenue

Latest reported$3.10M
ATRS Quarterly Deferred Revenue ($0.00 → $3.10M)
High-resolution chart · PNG

ATRS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
3,100,000
4,427,000
3,804,000
2,675,000
1,570,000
3,943,000
3,277,000
2,341,000
2,048,000
1,738,000
1,412,000
547,000
1,537,000
1,018,000
8,311,000
8,327,000
4,547,000
2,794,000
2,842,801
3,483,297
3,928,590
6,149,087
5,801,902
6,494,770
5,254,028
5,143,825
1,980,710
3,029,854
7,435,518
8,520,517
6,891,503
7,306,921
6,182,342
4,531,220
633,970
1,288,212
1,466,020
2,157,016
1,929,430
2,968,628
3,176,895
5,644,278
3,278,789
3,250,516
3,841,278
3,080,062
2,947,856
3,644,066
4,167,643
5,311,516
4,643,410
451,795
620,502
1,179,820
705,113
1,250,519
1,075,055
964,673
1,056,970
763,688
874,972
1,014,337
525,015
657,492
584,719
604,143
718,197
491,684
541,070
547,006
816,822
825,071
831,071
809,945
677,702
2,946,460
3,110,598
1,859,288
2,083,513
2,486,538
1,660,381
1,511,198
1,666,016
1,485,299
1,459,614
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.